SCHEMBL4896142

SCHEMBL4896142

COCCNC(=O)c1c(O)c2ncc(Cc3ccc(F)cc3C(=O)N3CCOCC3)cc2n(C)c1=O

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.37
CNR2 P34972 7/20 0.36
NTRK1 P04629 3/20 0.36
PIK3CA P42336 3/20 0.36
LRRK2 Q5S007 1/20 0.36
PDE10A Q9Y233 1/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
LMNA P02545 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895081 0.93 NTRK1 (0.37) NTRK1KMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL4905923 0.93 KDM4E (0.40) CNR1CNR2NTRK1PIK3CAPDE10A
SCHEMBL4906678 0.88 KMT2A (0.42) CNR1CNR2PIK3CAKMT2A
SCHEMBL4904935 0.87 MEN1 (0.41) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL4575789 0.87 NTRK1 (0.39) CNR1CNR2NTRK1KMT2AMEN1
SCHEMBL4576410 0.87 MEN1 (0.39) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL4907461 0.86 PIK3CA (0.41) CNR1CNR2PIK3CAKMT2A
SCHEMBL4904776 0.86 MEN1 (0.40) CNR2KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL16021048 0.85 MEN1 (0.41) KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL4906357 0.85 KDM4E (0.41) CNR2NTRK1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214527-A1 Hiv Integrase Inhibitors API5, ING2, SAMHD1 CNR1 4694/4885CNR2 4815/4885NTRK1 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.